ClinConnect ClinConnect Logo
Search / Trial NCT06778642

Postoperative Analgesic Comparison of SPSI Block and SAP Block in Video-Assisted Thoracoscopic Surgery (VATS)

Launched by ULUDAG UNIVERSITY · Jan 12, 2025

Trial Information

Current as of July 02, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how effective two types of pain relief methods are for patients who have undergone Video-Assisted Thoracoscopic Surgery (VATS), a minimally invasive procedure for chest issues. The two methods being compared are called the Serratus Posterior Superior Intercostal Plane Block (SPSI Block) and the Serratus Anterior Plane Block (SAP Block). The goal is to find out which method helps patients feel less pain after their surgery.

To participate in this study, you need to be between 18 and 80 years old and scheduled for VATS at Uludağ University Faculty of Medicine Hospital. You should also be in good overall health, classified as ASA I, II, or III, which means you have a mild to moderate medical condition. However, if you have certain health issues, like allergies to the medications used, bleeding problems, or severe heart or kidney conditions, you would not be eligible for this trial. If you join, you will receive one of the pain relief methods after your surgery and help researchers understand which one works better for managing pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients aged 18 to 80 years undergoing Video-Assisted Thoracoscopic Surgery (VATS)
  • Scheduled at Uludağ University Faculty of Medicine Hospital Operating Room
  • Classified as ASA I, II, or III according to the American Society of Anesthesiologists (ASA) criteria
  • Exclusion Criteria:
  • Allergy to local anesthetics or contraindications to bupivacaine
  • Known or suspected coagulopathy
  • Infection at the injection site
  • History of thoracic surgery
  • Severe neurological or psychiatric disorders
  • Severe cardiovascular disease
  • Liver failure
  • Renal failure (glomerular filtration rate \< 15 ml/min/1.73 m²)
  • Chronic opioid use

About Uludag University

Uludağ University is a leading academic institution located in Bursa, Turkey, renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Uludağ University leverages its extensive expertise and resources to facilitate innovative research initiatives aimed at improving healthcare outcomes. The university's collaborative approach fosters partnerships with healthcare professionals, researchers, and industry stakeholders, ensuring rigorous adherence to ethical standards and regulatory guidelines. Through its clinical trials, Uludağ University aims to contribute significantly to the scientific community and enhance the understanding of various medical conditions and treatments.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported